NCT05522387 2026-02-27An Open-Label Extension of XPro1595 in Patients With Alzheimer's DiseaseInmune Bio, Inc.Phase 2 Terminated11 enrolled
NCT03371420 2023-04-18PET Imaging of Subjects Using 124I-PU-ADSamus Therapeutics, Inc.Phase EARLY_PHASE1 Terminated5 enrolled